Thus, combinations of inactivated herpesviruses (especially HHV-6A and HSV-1) and HERV-H antigens greatly increased immune responses in vitro in PBMCs from MS patients and healthy controls [204]. This evidence concerns the gene FUT1 and myeloid sarcoma.